Platinum Tumbles as Traders Reduce Risk on Middle East Tension
Platinum fell by the most in more than three years as market tightness began to ease and conflict in the Middle East prompted global investors to reduce risk.
Israel launched strikes across Iran, targeting nuclear facilities and killing top military commanders in a major escalation against its chief adversary. Most risk-on assets including industrial metals pushed lower in response, with platinum prices tumbling as much as 6.4% Friday, the biggest intraday drop since March 2022.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Bitcoin Remains Defiant Amid Escalating Middle East Conflict and Trade War Fears
Bitcoin hovered around $105,100 on June 14, down 0.22% over the past 24 hours as traders digested geopolitical tension. Price action remained relatively tight, with BTC moving within a $2,090 range from $104,220 to $106,135. The largest moves occurred overnight in Asia trading, where Bitcoin briefly dipped below $104,200 before rebounding on high volume. Much of the recent volatility has been driven by developments in the Middle East. The Israel-Iran war, which some analysts fear could spread to other parts of the Middle East, combined with trade tensions between the U.S. and some of its key trading partners, has unsettled risk markets. More than $1.1 billion in crypto liquidations were recorded during the initial wave of conflict headlines, though bitcoin has shown resilience in the aftermath. Traders appear to be leaning bullish in the medium term, as BTC continues to hold a pattern of higher lows despite intraday wobbles. Profit-taking near $106,000 capped upside momentum, but support near $105,000 continues to draw buyers on dips. Market participants are watching this range closely, particularly as safe-haven demand and risk sentiment remain intertwined. While short-term headlines continue to drive volatility, the broader structure suggests BTC is consolidating rather than reversing. If support around $104,950 holds, Bitcoin may attempt another push above $106,200. Technical Analysis Highlights BTC traded in a $2,090 range from $104,182 to $106,272 over the past 24 hours. A key bounce occurred at $104,182 with 15,342 BTC traded during the recovery. Resistance formed near $106,200 amid consistent profit-taking. A rising trendline of higher lows remains intact. Psychological support at $105,000 is holding for now. Recent price range: $104,875 to $105,202 in the last hour. A sharp dip below $105K at 07:19 reversed quickly, with $105,200 acting as near-term resistance. Final 15-minute candles showed minor exhaustion, but volume patterns suggest accumulation on dips. Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk's full AI Policy.
CNBC
an hour ago
- CNBC
These stocks, including Oracle, are among the most overbought on Wall Street
Several stocks could soon be due for pullbacks after seeing sizable gains this week, according to a widely-used technical indicator. Stocks took a hit Friday after Israel launched a series of airstrikes on Iran in the largest attack on the Islamic Republic since the Iran-Iraq war in the 1980s. Following Israel's attack, which killed at least three of Iran's senior military leaders, Iran launched more than 100 drones toward Israel. The attacks sent investors out of stocks and into safe-haven assets like the U.S. dollar and gold, both of which rallied Friday. The S & P 500 finished Friday's session down more than 1%, making the week-to-date loss 0.4%. The Nasdaq Composite and the Dow Jones Industrial Average also finished in the red for the period, posting a loss of 0.6% and 1.3%, respectively, on the week. Using the stock screener tool , CNBC Pro looked for the most overbought and oversold stocks by measuring their 14-day relative strength index, or RSI. An RSI reading above 70 can indicate that a stock may be overbought and move lower in the near term, while an RSI below 30 might signal that a stock is oversold and see a future move higher. Oracle was the most overbought stock in the S & P 500 this past week, with an RSI around 90.4. Shares of the software maker rose almost 8% on Friday, reaching an all-time high and extending Thursday's 13% rally. Over the course of the entire week, Oracle surged 24%. Analysts surveyed by LSEG have an average price target on the stock of around $205, implying almost 5% downside from Friday's closing level, although many of those targets may rise in the wake of Oracle's latest earnings this week. Most of the week's gains came after Oracle's fiscal fourth quarter results topped Street estimates. CEO Safra Catz said cloud infrastructure revenue is expected to rise more than 70% in fiscal 2026, adding that the fiscal year "will be even better as our revenue growth rates will be dramatically higher." Micron Technology also showed up among the most overbought stocks, with an RSI of 85.1. Shares jumped more than 6% over the past week, its third straight weekly gain, putting its year-to-date gain at more than 37%. The stock was marginally lower on Friday, snapping a nine-day advance. Thursday, Micron announced plans to invest about $200 billion in U.S. semiconductor manufacturing in a move that will create 90,000 direct and indirect jobs. J.M. Smucker was on the week's oversold list, with an RSI around 27. Though most Wall Street analysts rate the peanut butter and jelly maker no more than a hold, according to LSEG ,the consensus price target of $113 implies more than 18% upside from Friday's close. Shares came under pressure in the past week, falling 14%, after fiscal fourth-quarter revenue of $2.14 billion missed the $2.18 billion that analysts polled by FactSet had expected, though earnings topped estimates. Smucker's full-year earnings guidance also missed Street expectations. The stock has now fallen in seven out of the past eight weeks. PG & E shares fell 13% this week, its fourth straight weekly decline, and the California utilility now has an RSI of 20.6. The stock has taken a beating this year, tumbling 32% compared to 1.6% rise in the S & P 500.
Forbes
2 hours ago
- Forbes
5 Stocks To Buy As The Stock Market Nears All-Time Highs
The stock market's remarkable recovery from earlier 2025 volatility has investors questioning whether it's still a good time to buy. The S&P 500 hit 6,000 for the first time since February following strong economic data. Subsequently, it fell to a low of 4,910 in April due to Tariff concerns and investor pessimism as Trump rolled out his new economic plans. In May, it bounced back, and despite ongoing Tariff concerns, the S&P 500 closed out the Month with a gain of more than 6%, its best monthly performance since November 2023. Current market conditions present both opportunities and challenges for investors. While some analysts worry about overvaluation, earnings estimates have been revised to 7% growth for 2025, suggesting markets are no longer priced for an adverse outcome. The recent recovery from the spring market correction demonstrates the resilience of quality companies with strong fundamentals. The methodology for selecting these five stocks focused on companies with compelling growth prospects, strong competitive positions and the ability to thrive in various market conditions. I analyzed quantitative metrics, including revenue growth, profit margins and valuation ratios, while also considering qualitative factors such as market leadership, innovation capabilities and long-term strategic positioning. These selections represent diverse sectors that are well-positioned to benefit from current economic trends. Tesla remains the world's leading electric vehicle manufacturer, with expanding operations in energy storage, solar panels and autonomous driving technology. The company has successfully scaled production across multiple global facilities while maintaining industry-leading margins. Despite recent volatility stemming from tensions around Elon Musk's involvement in the U.S. Department of Government Efficiency (DOGE), which temporarily cut $152 billion from Tesla's market capitalization, the underlying business fundamentals remain strong, with growing EV adoption worldwide. Tesla's market leadership in the rapidly expanding electric vehicle (EV) sector positions it perfectly for long-term growth. The company's vertical integration strategy, from battery production to charging infrastructure, creates substantial competitive advantages. Recent developments in autonomous driving technology and energy storage solutions provide multiple revenue streams beyond traditional automotive sales. The temporary price decline from Elon Musk's entanglement with politics and perhaps declining mental stability creates an attractive entry point for long-term investors. Tesla's global expansion, particularly in emerging markets, combined with decreasing battery costs and improving production efficiency, suggests strong earnings growth potential. The company's innovation pipeline, which includes robotaxi services and energy grid solutions, offers significant upside beyond its current valuations. Microsoft stands as one of the world's most valuable companies, dominating cloud computing through Azure, productivity software via Office 365 and emerging AI technologies. The company has successfully transitioned from traditional software licensing to subscription-based services, creating predictable recurring revenue streams. Microsoft shares advanced significantly in early May, with AI developments reigniting investor interest. Microsoft's diversified business model provides stability and growth across multiple technology sectors. The company's leadership in cloud computing continues to expand as enterprises accelerate their digital transformation initiatives. Azure's growth trajectory, combined with Microsoft's early integration of AI across its product suite, positions the company perfectly for the next wave of technology. Microsoft recently secured a significant deal to bring 1 million Copilot users on board from a single enterprise client, potentially generating over $350 million annually. This adds momentum to its AI strategy, following strong Q3 earnings and record-high share prices. With Azure growth holding steady and demand for AI-integrated tools on the rise, the deal reinforces Microsoft's position as a market leader. At the same time, the stock trades at a premium, continued execution in cloud and AI could justify the valuation, and support further upside. Palantir specializes in big data analytics and artificial intelligence platforms, serving government agencies and commercial enterprises. The stock has surged nearly 75% this year, leading the Nasdaq 100's constituents so far in 2025, driven by expanding federal government contracts and growing commercial adoption. The company's unique position in data integration and analysis creates substantial competitive moats. Palantir's government contracts provide stable, long-term revenue streams with high switching costs due to the mission-critical nature of their platforms. The company's work for the federal government has grown substantially, creating predictable cash flows that support aggressive growth investments. The expanding commercial segment demonstrates Palantir's ability to monetize its technology beyond government applications. The company's AI and machine learning capabilities position it perfectly for the current technology cycle. As organizations increasingly rely on data-driven decision making, Palantir's platforms become essential infrastructure. The high barriers to entry in this specialized market, combined with strong customer retention rates, suggest sustainable competitive advantages that justify premium valuations. Johnson & Johnson represents one of the world's largest healthcare conglomerates, with diversified operations spanning pharmaceuticals, medical devices and consumer products. The company sustains a broad economic moat through outstanding cash flow generation, a growing research pipeline, and multiple revenue sources. Recent strategic acquisitions, including the $14.6 billion purchase of Intra-Cellular, a biopharmaceutical business, demonstrate ongoing portfolio optimization. Johnson & Johnson's defensive characteristics make it an ideal holding during market volatility, while its pharmaceutical pipeline provides significant growth potential. The company's consistent dividend payments, supported by strong cash flows, offer income stability that's particularly attractive in uncertain economic environments. J&J's global reach and diversified product portfolio provide resilience against regional economic downturns. The healthcare sector's demographic tailwinds, driven by aging populations worldwide, create sustained demand for Johnson & Johnson's products and services. The company's strong research and development capabilities, combined with strategic acquisitions, continuously refresh its product pipeline. J&J's excellent credit rating and financial flexibility enable continued investment in growth opportunities while maintaining shareholder returns. HIMS & Hers operates a direct-to-consumer telemedicine platform, offering personalized healthcare solutions that include treatments for hair loss, sexual wellness, mental health and skincare. The company reported a significant increase in net income for the fourth quarter, generating $26 million in net income, up from $5 million in the same period last year. The platform's subscription-based model creates recurring revenue streams with high customer lifetime value. The digital healthcare revolution accelerated by the pandemic has created permanent behavioral changes in how consumers access healthcare services. HIMS capitalizes on this trend by offering convenient and affordable alternatives to traditional healthcare delivery. The company's direct-to-consumer model eliminates intermediaries, improving margins while reducing costs for patients. HIMS addresses large, underserved markets where traditional healthcare often fails to provide adequate solutions. The company's focus on stigmatized conditions creates intense customer loyalty and reduces price sensitivity. Expanding product offerings and geographic reach provide multiple growth vectors, while the subscription model ensures predictable revenue growth. The digital-first approach positions HIMS perfectly for the future of personalized healthcare delivery. Bottom Line These five stocks represent compelling opportunities as markets near all-time highs, each offering unique advantages for different investor profiles. Tesla provides exposure to the electric vehicle (EV) revolution, Microsoft offers stability with AI growth, Palantir captures the data analytics boom, Johnson & Johnson delivers defensive income with growth potential, and HIMS capitalizes on the digital healthcare transformation. While market timing remains uncertain, these quality companies with strong competitive positions and compelling growth prospects offer attractive risk-adjusted returns for long-term investors navigating today's elevated market levels.
